Log In
BCIQ
Print this Print this
 

PGN-321

  Manage Alerts
Collapse Summary General Information
Company bluebird bio Inc.
DescriptionHoming endonuclease
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$155.7M

0

$135.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/30/2014

$155.7M

0

$135.0M

Get a free BioCentury trial today